Meal Effects on Nutrient Tracking
(Microdialysis Trial)
Trial Summary
Do I need to stop taking my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently on anticoagulants (blood thinners).
What data supports the effectiveness of the treatment Meal set A, Meal set B, Meal set C, Meal set D?
How does the treatment in the 'Meal Effects on Nutrient Tracking' trial differ from other treatments for nutrient tracking?
This treatment is unique because it focuses on tracking nutrient intake at the level of individual meals rather than just overall dietary patterns or individual nutrients. This approach may provide more detailed insights into how specific meals contribute to overall diet quality and nutrient intake.678910
What is the purpose of this trial?
The goal of this clinical trial is to establish the relationship between macronutrient food intake and the resulting blood and intersticial fluid (ISF )levels of small molecule markers, as well as, validate wearable optical readers and data fusion algorithms to accurately predict individual-specific macronutrient availability in real time.The study involves 1 screening visit of approximately 2 hours and up to 4 study days of approximately 14 hours. Subjects will be asked to arrive in the fasted state on all study days. Fasting prior to screening is not required. On the screening visit, body weight, height, and body composition by Dual-energy X-ray absorptiometry (DXA) will be measured. In addition, habitual dietary intake, physical activity level (PASE), and quality of life (SGRQ-C) will be assessed.
Research Team
Nicolaas E Deutz, Ph.D.
Principal Investigator
Texas A&M University
Michael McShane, PhD
Principal Investigator
Texas A&M University
Eligibility Criteria
This trial is for individuals with diabetes and issues with amino acid metabolism. Participants should be willing to fast before study days, undergo body measurements like weight and height, and have their diet, physical activity, and quality of life assessed.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Study Days
Participants undergo study procedures including blood sampling and meal consumption
Follow-up
Participants are monitored for safety and effectiveness after study days
Treatment Details
Interventions
- Meal set A
- Meal set B
- Meal set C
- Meal set D
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas A&M University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator